Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0030567 (Parkinson's disease)
 63,064 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A patient with progressive neurological deterioration characterized by cognitive impairment, myoclonus, Parkinson's syndrome, an abnormal electroencephalogram and fasciculations was considered for brain biopsy for suspected Creutzfeldt-Jakob disease. Complete clinical recovery followed discontinuation of lithium and nortriptyline. Awareness of this unusual drug-induced Creutzfeldt-Jakob like syndrome can avoid costly, invasive and unnecessary investigative procedures.
J Psychiatry Neurosci 1992 Sep
PMID:Drug-induced Creutzfeldt-Jakob like syndrome. 139 Jun 20

A computerized EEG (cEEG) study was performed in two groups of patients with dementia of the Alzheimer type (DAT) and with Parkinson's disease with dementia (PDD). Compared to control subjects suffering from Parkinson's disease without dementia, both groups demonstrated similar slowing down of background activity. However, there were more low frequency components, defined as between 2.5-7 Hz, and less topographical differentiation in PDD than in DAT. Furthermore, more severe impairment of cognitive functions was observed in DAT, but their psychometric score correlated with slowing down of EEG only in DMP. These observations emphasize the influence of the subcortical/cortical axis both in dementia of Parkinson's disease and in the neurophysiology of the EEG.
Neurophysiol Clin 1992 Sep
PMID:[Comparative study by computerized EEG of dementia of the ALzheimer type and Parkinson's disease with dementia]. 140 44

Primary cultures were derived from human fetal ventral mesencephalon and cerebral cortex at 7-11 weeks gestation, and from fetal rat mesencephalon and cortex at embryonic day 14-15. Immunohistochemical analysis of the mesencephalic cultures using antibodies to tyrosine hydroxylase (TH) showed between 0.1-0.5% of human cells to be TH positive and 0.1-1% of rat cells to be TH positive. HPLC analysis of extracts from the cultures showed that they had the ability to synthesise and store dopamine. Implantation of the cultured human and rat mesencephalic tissue into a 6-hydroxydopamine rat model of Parkinson's disease produced marked recovery from amphetamine induced rotational asymmetry in the recipient rats, but no such recovery was observed following implantation of cortical cultures. Histological examination demonstrated the presence of surviving human mesencephalic and cortical grafts at least 6 months after implantation. Implants of cultured fetal rat tissue were less obviously but still significantly effective in these experiments. These rat tissue grafts were detectable for periods of at least 6-8 weeks by histological staining.
Neurochem Res 1992 Sep
PMID:The properties of cultured fetal human and rat brain tissue and its use as grafts for the relief of the parkinsonian syndrome. 140 76

From mid-October 1989 to mid-July 1990 all newly admitted residents to Bury Local Authority Residential Homes were comprehensively medically screened. In a series of 100 residents eight had early Parkinson's disease (six of them hitherto undiagnosed). Seven showed evidence of Vitamin C deficiency. Of the seven showing evidence of deficiency, four suffered from early Parkinson's disease. Of the 93 without evidence of Vitamin C deficiency only four had Parkinson's disease. This indicates a significantly higher prevalence of Parkinson's disease in the group with Vitamin C deficiency (P less than 0.001 using Fisher's exact).
Public Health 1992 Sep
PMID:Detection of subclinical ascorbate deficiency in early Parkinson's disease. 141 Feb 24

In this study we evaluated the efficacy of physical therapy together with drug therapy in a group of parkinsonian patients, compared with a group of patients treated using drug therapy only. The physical therapy program lasted four months and included passive and active mobilization exercises, adopted for postural control and equilibrium, walking and prevention of contractures and ankylosis. The assessment was accomplished by means of clinical rating scales and motor performance tests. Patients treated by means of physiotherapy showed an improvement at the end of the study in both clinical scales and motor performance tests. This improvement was noted in both patients with less severe and more severe symptoms as well as in those with shorter and longer disease duration. It is not easy to assess the role played by physical therapy due to the difficulty of an objective evaluation; our results, however, show an improvement in the functional performance of patients and suggest the usefulness of physical therapy associated with drug therapy in a comprehensive treatment for Parkinson's disease.
Scand J Rehabil Med 1992 Sep
PMID:Rehabilitation and Parkinson's disease. 141 61

Much evidence suggests that parkinsonian rigidity is due to hyperactivity of a reflex arc. While tendon jerk and H reflex are not modified in Parkinson's disease (PD), the long-latency component of stretch reflex (LLR) shows an increased size in PD. It has been proposed that this modification could account for rigidity. We studied in 14 PD patients and 8 normal subjects the stretch reflex of the quadriceps femoris. The muscle was stretched by a torque motor in two experimental sets: at rest and with voluntary background activity. Latency, duration and size of the reflex were compared in two groups; correlation between size of the reflex and rigidity was investigated. A lower threshold for the reflex was found in PD patients in trials at rest, and LLR showed increased size and duration in trials with background activity. No clear relationships between these data and rigidity were demonstrated.
Acta Neurol Scand 1992 Sep
PMID:Stretch reflex of quadriceps femoris and its relation to rigidity in Parkinson's disease. 141 37

In the human brain, receptor binding sites for angiotensin are found in the striatum and in the substantia nigra pars compacta overlying dopamine-containing cell bodies. In contrast, angiotensin-converting enzyme occurs in the substantia nigra pars reticulata and is enriched in the striosomes of the striatum. In this study, using quantitative in vitro autoradiography, we demonstrate decreased angiotensin receptor binding in the substantia nigra and striatum of postmortem brains from patients with Parkinson's disease. In the same brains the density of binding to angiotensin-converting enzyme shows no consistent change. We propose, from these results, that angiotensin receptors in the striatum are located presynaptically on dopaminergic terminals projecting from the substantia nigra. In contrast, the results support previous studies in rats demonstrating that angiotensin-converting enzyme is associated with striatal neurons projecting to the substantia nigra pars reticulata. These findings raise the possibility that newly emerging drugs that interact with the angiotensin system, particularly converting enzyme inhibitors and new nonpeptide angiotensin receptor blockers, may modulate the brain dopamine system.
Ann Neurol 1992 Sep
PMID:Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. 141 3

This report details the emergence of a progressive parkinsonian syndrome, dementia and behavioural disturbance in a 33 year-old woman which can be dated to the delivery of her first child. The findings of this case indicate that cortical Lewy body disease should be considered in any patient with temporoparietal dementia and idiopathic Parkinson's disease irrespective of the age of onset.
Aust N Z J Psychiatry 1992 Sep
PMID:Diffuse Lewy body disease and progressive dementia in a young woman. 141 40

The conductivity of motor neurons in 26 aged females (mean age 79 years) was analyzed by the conventional conduction method and by pulsed magnetic stimulation and compared with that in 14 younger controls. In aged people, slow motor conduction velocities were found in peripheral nerves. Central motor conduction time (CMCT) in relaxed muscle was shorter in the aged people, although CMCT was normal in mildly contracted muscle. These findings coincide with the results studied in Parkinson's disease, although these subjects were not diagnosed as having Parkinson's disease. Aged people generally have an anteflexed posture, slow movements, and poor postural reflexes, and have been reported to have a decrease in the dopamine level which is relatively earlier than that of other transmitters in the basal ganglia. This may account for the present finding that aged people have neurophysiological abnormalities in CNS which are similar to those in Parkinson's disease.
Intern Med 1992 Sep
PMID:Central motor conductivity in aged people. 142 13

Event-related potentials (ERPs) generated during the performance of visual discrimination tasks were studied in 31 patients with Parkinson's disease, 9 patients with Alzheimer's disease, and 37 normal control subjects. Actively and passively evoked P3 components (P3b and P3a) were respectively identified as the components of the P3 response to infrequent target stimuli and infrequent non-target stimuli. Both the P3a and P3b latencies were significantly prolonged by normal aging. Nine of the Parkinson's disease patients showed a P3b latency above the 95% confidence limit of the age-adjusted regression line based on the normal controls, while only on patient had a prolonged P3a latency. In 6 patients with demented Parkinson's disease, the P3b latency was significantly longer than in 15 age-equivalent normal subjects, although no significant difference was found in the P3a latency. On the other hand, patients with Alzheimer's disease showed significant prolongation of both the P3a and P3b latencies compared to the normal controls. Furthermore, there was a significant difference in P3a latency between patients with demented Parkinson's disease and those with Alzheimer's disease. These results suggest that the automatic processing stage associated with P3a may be less impaired than the attention-controlled processing reflected by P3b in patients with Parkinson's disease, and also indicate that there may be some differences in the changes of cognitive processing caused by Parkinson's disease and Alzheimer's disease.
J Neurol Sci 1992 Sep
PMID:Actively and passively evoked P3 latency of event-related potentials in Parkinson's disease. 143 80


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>